Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Yamanouchi reports squalene synthase inhibitors

Aug. 9, 1996

Alfa Wasserman reveals antioxidant hypolipidemic compounds

Aug. 9, 1996

New formulation of salmon calcitonin undergoes U.S. phase I trial

Aug. 9, 1996

Duphar reports Vitamin D compounds with multiple therapeutic activity

Aug. 9, 1996

Comparative study results of Systen and Menorest

July 26, 1996

Prostaglandin E1 regimen shows positive results for male erectile dysfunction

July 26, 1996

ALT-766: New AGE cross-link breaker from Alteon

July 26, 1996

Phase III results indicate Ergoset's effectiveness and safety

July 26, 1996

Selective beta3-adrenoceptor agonists in Dainippon's pipeline

July 26, 1996

Ibex licenses technology from Centre for Applied Microbiology and Research

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...